ISMPP Publication Primer Practice Exam

These questions are part of the practice quiz. Start practicing

• According to COPE, what is the primary purpose of retractions?
• What term is used for an author who takes overall responsibility for the integrity of a study and its report?
• Is it necessary to cite a large number of sources to support a single claim?
• What is GPP3 in the context of medical publications?
• What does the term "dissemination" refer to in the context of clinical data?
• Who established a clinical trials registry for trials conducted in the European Union?
• Which dimension is NOT typically considered when evaluating a journal?
• What is the purpose of an Acknowledgment in a publication?
• What does a Corporate Integrity Agreement (CIA) typically require a pharmaceutical company to do?
• What is one of the main purposes of having a Publication Steering Committee (PSC)?
• Which organization is regarded as the "gold standard" for publication recommendations?
• What is the primary goal of having stringent regulations regarding educational programs sponsored by the industry?
• When should authorship guidelines and qualifications be determined?
• Which of the following best describes the audience for ICMJE recommendations?
• What is the main reason for including peer review in publication?
• Which group is crucial for generating congress abstracts and journal manuscripts in clinical research?
• What action should a journal editor take if there is clear evidence of misconduct associated with a publication?
• Which type of citation is preferred in medical publications?
• Which of the following documents are prepared for FDA approval?
• What role does publications play in the medical field?
• What is an essential element that the ICMJE recommendations aim to promote among authors?
• Which principle states that the contribution of professional writers should be acknowledged?
• What is life cycle management in the context of medical publication?
• What does MEDLINE primarily consist of?
• Which of the following is a requirement for pharma companies under a CIA?
• What is the primary purpose of tables in medical publications?
• Which characteristic is essential for a journal to be indexed in MEDLINE?
• Where must the payment information greater than $10 be reported annually?
• What is the role of a medical writer in manuscript preparation?
• Where should any additional findings that do not fit into primary outcomes be included?
• What does adherence to compliance ensure in medical publishing?
• What does a meta-analysis entail?
• What advantage does open access provide to readers?
• What should an author do if they wish to withdraw from authorship before publication?
• What aspect of research does the ICMJE directly address?
• What should be included in publications from new studies in Phase 4?
• Why is it necessary to provide detailed information on experimental controls?
• In which section should authors present the objective findings of their study?
• What was the primary reason for the development of the ISMPP Publication Primer?
• What does evidence-based medicine emphasize in patient care?
• Which subheadings are usually included in the Results section of a manuscript?
• What is a significant goal of the ICMJE recommendations regarding medical publications?
• Why do publications carry a heavy burden of responsibility?
• Which of the following is NOT typically a major element required for journal submissions?
• What is an important function of medical publications in relation to evidence?
• What tool can help the publication team identify effective target journals or congresses?
• By when must interventional clinical trials be registered according to the FDAAA?
• What do the ICMJE guidelines require from authors regarding their contributions?
• Which type of publication is primarily focused on educating patients?
• What type of articles are particularly influenced by ICMJE recommendations?
• What is a poster presentation in a conference context?
• What does compliance refer to in medical publications?
• What is the purpose of posting summaries of clinical study reports on a company website?
• What is a key component often included in systematic reviews?
• Which of the following is considered misconduct in research?
• What should submissions include to help others replicate the study?
• How can one obtain permission from a copyright holder?
• What does a narrative review provide?
• Should authors follow ICMJE authorship criteria at all times?
• If there is insufficient evidence to determine misconduct or errors, what is the recommended course of action?
• What is the purpose of peer-review in the context of medical publishing?
• Who are typically considered members of a Publication Steering Committee (PSC)?
• Which of the following is a critical component of the manuscript development process?
• What is the significance of posting summary results in a Clinical Trial Registry?
• In open access publications, is copyright usually transferred to the journal?
• When should authors ideally sign an authorship agreement?
• What is the purpose of post hoc analysis?
• Why do many journals require written permission for acknowledgment?
• Which group benefits from the guidelines established by the ICMJE recommendations?
• Which element is typically the most visible part of a medical article, as it is freely available on platforms like PubMed?
• Who typically comprises a Publication Steering Committee (PSC)?
• Which resource is most likely to assist an author with manuscript preparation?
• Which of the following best describes the role of a professional medical writer in a publication?
• Which of the following is NOT a type of medical publication?
• What does the STM agreement entail?
• What does ICMJE stand for?
• What can impact the authorship order of a publication?
• What does a Clinical Trial Registry provide?
• What is the focus of publications developed during Phase 2?
• What does the FDAAA require regarding clinical trial results?
• In the context of journal impact scores, what is an indicator of a high-impact journal?
• What is a common drawback associated with open access journals?
• Who negotiates CIAs with pharmaceutical companies?
• What is the focus of a case study in medical publications?
• What is the term for an industry-sponsored educational event held during an organization's meeting?
• What responsibility do authors have in terms of identifying contributors to a manuscript?
• The main focus of ethical standards in medical publications is to maintain what?
• ICMJE recommendations aim to reduce what type of publication bias?
• When does the FDA require investigational clinical trials to be registered?
• What influences the evolution of the publication ecosystem?
• What should be considered in publication planning?
• How does the impact factor influence author decisions regarding journal submissions?
• Where should ethical guidelines for human subjects be described in a manuscript?
• In which section are the interpretations of study results provided?
• Why might presenting data at a congress be beneficial?
• When are primary results of the trial required to be posted in the ClinicalTrials.gov database?
• What is a crucial aspect of the GATE Principles?
• In what area do the ICMJE recommendations primarily provide guidance?
• What type of review attempts to analyze all available literature on a subject systematically?
• How long does a Corporate Integrity Agreement usually last?
• What should an editor do if a small change is required in a publication?
• What is the main goal of the Sunshine Act?
• What is one of the purposes of keeping a company compliant as per the CIA?
• What usually triggers the enforcement of the CIA?
• What is the primary function of medical publications?
• Where should authors discuss the significance of their key findings?
• What key element is essential in a journal submission regarding copyright?
• Which type of journal typically has longer lead times for publication?
• What is the term for a brief summary submitted ahead of a conference meeting?
• What is a key role of a CMPP?
• What is the ultimate goal of publication planning?
• What do publications allow investigators to do?
• Which of the following describes a characteristic that distinguishes medical publications from other forms of media?
• According to ICMJE guidelines, what is required from authors regarding their contributions to the work?
• What does a systematic review aim to achieve?
• What is an objective of the ICMJE recommendations?
• What is the main characteristic of systematic reviews?
• What is the name of the act that requires pharma companies in the US to report payments over $10 to physicians?
• What are the fundamental requirements for clinical trials?
• Who are medical publications primarily a communication vehicle between?
• What factor is considered the best evidence in evidence-based medicine?
• Which of the following best describes the role of medical communications companies?
• What is the primary purpose of publications in relation to clinical trials?
• What action should be taken if an author does not understand the manuscript's language?
• What does the term 'misconduct' refer to in a research context?
• What are the primary objectives of the EQUATOR Network?
• What are research guidelines aimed at ensuring?
• What must authors do with all previously published work used to support their claims?
• What is the primary objective of a short communication?
• What is a key requirement of the FDAAA for registered clinical trials?
• What serves as a preview and summary of an article, helping readers decide if they want to read the full piece?
• What does an abstract usually appear as in a publication?
• Which type of journals are generally considered higher tiered?
• What is the main characteristic of Open Access Journals?
• What are Anti-Bribery and Corruption Laws primarily designed to address?
• What does ethics in publication refer to?
• What does the ICMJE focus on in relation to medical publications?
• What is a key element of good publication practice enforced during a CIA?
• Which guidelines provide principles on the conduct of clinical trials and communication of results?
• What type of publication typically does not require copyright transfer to the journal?
• What is the role of authors in manuscript approval?
• What type of information is typically included in the Results section?
• What does subset analysis primarily evaluate?
• What should authors consider if their chosen journal is not a good fit for their manuscript?
• What does the Sunshine Act require pharma companies to report regarding financial relationships?
• What defines plagiarism?
• Which of the following best describes the responsibilities defined within a PSC?
• What does a meta-analysis primarily summarize?
• Which of the following is NOT a member of a Cross-functional Publications Committee?
• Which element is not typically included in the publication planning process?
• What do medical publications primarily aim to achieve?
• Which guideline recommends the formation of a Publication Steering Committee (PSC)?
• What is an important aspect to remember about abstract submissions to congresses?
• Which of the following is a characteristic of a narrative review?
• Who typically covers the fee for Open Access publication charges?
• What type of materials should contain content of interest to motivated readers but does not fit in the main publication?
• What is a key step in the publication process?
• What is one of the purposes of Peer Reviewer Requests in journal submissions?
• What does AMWA stand for?
• What is the purpose of a Promotional Speakers' Bureau?
• Why might pharmaceutical companies not sponsor supplement publications?
• When does the FDA require the primary results of a trial to be posted in the clinical trial database?
• When does publication planning usually start?
• Which of the following best describes the focus of HEOR?
• What is generally recommended when choosing a journal based on the speed of publication?
• What defines a supplement in the context of publication?
• What is peer review primarily used for?
• What type of abstract is usually longer and may include a table?
• What are different examples of funding sources for clinical research?
• Which of the following is NOT a requirement for clinical trials?
• What does HEOR stand for?
• What type of analysis involves unexpected results analyzed after a trial's completion?
• Which of the following is NOT a type of publication that can be developed in Phase 1?
• What is the benefit of conducting a subset analysis?
• What must be done before reusing published material?
• What can be a potential outcome of failing to adhere to permission requests for published material?
• Who are considered stakeholders in the publication process?
• What is a key consideration regarding clinical trial posting during publication planning?
• How should authorship conflicts be resolved according to best practices?
• What is the name of the US law that requires manufacturers to report transfers of value to physicians and teaching hospitals?
• What does a meta-analysis do?
• Why is it important for authors to follow ICMJE recommendations?
• If an author has a lengthy discussion with you that leads to significant changes in a publication, should you be acknowledged?
• Before using another person's copyrighted work, what must be obtained?
• Who is responsible for the initial assessment of a manuscript's relevance to a journal?
• When should a Publication Steering Committee (PSC) be formed?
• What is the purpose of the TEST Act?
• When are primary trial results required to be posted on a clinical trial registry site in the US?
• What is the purpose of including demographics in the Results section?
• Which of the following elements is commonly included in an abstract?
• What is the primary role of the Publication Committee?
• What does the Authors' Submission Toolkit assist authors with?
• Which of the following is considered an essential component of publication ethics?
• What responsibility does the detection of fraud and plagiarism primarily rest upon?
• What is an example of an authorship conflict?
• What is one of the roles of the publication lead within a PSC?
• Which guideline recommends that manuscripts include statements acknowledging contributions from various individuals and organizations?
• What is a requirement for reuse of published material according to ethical guidelines?
• What is typically included in structured research guidelines?
• Where should authors list the limitations of their research?
• What is a potential downside of starting with higher tiered journals?
• Which subheading is typically included in the Methods section of a manuscript?
• Which organization is the largest devoted to education and training for medical writers?
• Which of the following is NOT a consideration when deciding on a journal for publication?
• What types of publications are typically developed during Phase 3?
• What does it mean if a pharmaceutical company is subject to a Corporate Integrity Agreement (CIA)?
• What does ISMPP GPP3 provide guidance on?
• What type of publications can be developed in Phase 4?
• Why may secondary manuscripts be developed?
• What ethical step must an author take regarding the medical writer?
• What does a placeholder abstract indicate?
• What is one effective way to engage authors who have not critiqued a publication?
• What is the forum for public disclosure of data from clinical trials?
• Which document serves to protect trial information until public posting?
• What should the introduction of a paper present?
• How can you avoid potential authorship conflicts?
• Which type of manuscript is typically in greater detail regarding original research?
• What is the primary goal of a strategic publication plan?
• What role does an independent review organization play in a CIA?
• What should be confirmed with authors during the KO call?
• What is considered a key aspect of medical publication planning?
• What is one primary reason for the development of the ICMJE recommendations?
• What must authors do regarding medical writing assistance?
• What term describes the diverse community influenced by guidelines, standards, and compliance mandates in publishing?
• What is a Corporate Integrity Agreement (CIA) associated with?
• What is a potential consequence of irresponsible publication?
• The main purpose of retractions, according to the Committee on Publication Ethics (COPE), is to ____________.
• According to the FDA Amendments Act (FDAA), when must summary results information be reported?
• What aspect of transparency is most emphasized in publication ethics?
• Is there a universal guide for ranking authorship?
• What are the consequences of not requesting permission to reuse published material?
• Which of the following is a focus of the ICMJE recommendations?
• What is typically highlighted in the discussion section of a manuscript?
• When must all interventional clinical trials be registered according to the FDAA?
• Who is typically referred to as an Academician?
• What does OASPA stand for?
• If there is clear evidence of misconduct associated with a publication, a journal editor may ____________ a previously published paper.
• Where should a detailed description of trial design and patient populations be included?
• What should an abstract briefly describe?
• Which of the following allows for public access to publications without subscription?
• Who should refer to the ICMJE recommendations when preparing medical articles?
• How do the ICMJE recommendations aim to influence medical journal articles?
• What is the end result and primary deliverable of research?
• Who usually governs the authorship process in clinical research?
• When should authorship be discussed in the publication process?
• Where is the information reported under the Sunshine Act collected and posted?